According to Wall Street analysts Alibaba Health Information Technology ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: What is Alibaba Health Information Technology ’s EPS estimate?

Alibaba Health Information Technology ’s EPS estimate is <0.01.

Q: How many shares outstanding does Alibaba Health Information Technology have?

Alibaba Health Information Technology has 16,091,826,000 shares outstanding.

Q: What happened to Alibaba Health Information Technology ’s price movement after its last earnings report?

Alibaba Health Information Technology reported an EPS of $0.008 in its last earnings report, beating expectations of $0.008. Following the earnings report the stock price went same 0%.

336 Followers

ALBHF Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range$0.31 - $0.80

Previous CloseN/A

Volume1.43K

Average Volume (3M)2.00K

Market Cap

$6.84B

Enterprise Value$77.32B

Total Cash (Recent Filing)$580.16M

Total Debt (Recent Filing)$200.00M

Price to Earnings (P/E)40.7

Beta1.28

Next Earnings

May 27, 2025

EPS Estimate

<0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding16,091,826,000

10 Day Avg. Volume2,373

30 Day Avg. Volume1,999

Standard Deviation0.20

R-Squared0.01

Alpha-0.00599

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)3.04

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market Cap11.31

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$0.60

Price Target Upside36.36% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering5

Alibaba Health Information Technology News

PremiumCompany Announcements

Alibaba Health’s New RSU Grants Aim to Retain Talent

1M ago

PremiumCompany Announcements

Alibaba Health Reports Robust Growth in 2024 Earnings

2M ago

PremiumCompany Announcements

Alibaba Health Sees Strong Growth in Revenue and Profit

2M ago

PremiumCompany Announcements

Alibaba Health Schedules Board Meeting to Review Interim Results

3M ago

PremiumCompany Announcements

Alibaba Health Rewards Employees with Equity Grants

4M ago

PremiumCompany Announcements

Alibaba Health Announces Board Chair’s Role Change

5M ago

PremiumCompany Announcements

Alibaba Health Unveils New Board Structure

5M ago

PremiumCompany Announcements

Alibaba Health Gains Strong Shareholder Support at AGM

5M ago

See More ALBHF News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

1.35% Mutual Funds

― Other Institutional Investors

93.91% Public Companies and

Individual Investors

Detailed Ownership Overview >

ALBHF FAQ

What was Alibaba Health Information Technology ’s price range in the past 12 months?

Alibaba Health Information Technology lowest stock price was $0.31 and its highest was $0.80 in the past 12 months.

What is Alibaba Health Information Technology ’s market cap?

Alibaba Health Information Technology ’s market cap is $6.84B.

When is Alibaba Health Information Technology ’s upcoming earnings report date?

Alibaba Health Information Technology ’s upcoming earnings report date is May 27, 2025 which is in 123 days.

How were Alibaba Health Information Technology ’s earnings last quarter?

Alibaba Health Information Technology released its earnings results on Nov 13, 2024. The company reported $0.008 earnings per share for the quarter, beating the consensus estimate of $0.008 by <$0.001.

Is Alibaba Health Information Technology overvalued?

According to Wall Street analysts Alibaba Health Information Technology ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alibaba Health Information Technology pay dividends?

Alibaba Health Information Technology does not currently pay dividends.

What is Alibaba Health Information Technology ’s EPS estimate?

Alibaba Health Information Technology ’s EPS estimate is <0.01.

How many shares outstanding does Alibaba Health Information Technology have?

Alibaba Health Information Technology has 16,091,826,000 shares outstanding.

What happened to Alibaba Health Information Technology ’s price movement after its last earnings report?

Alibaba Health Information Technology reported an EPS of $0.008 in its last earnings report, beating expectations of $0.008. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Alibaba Health Information Technology ?

Currently, no hedge funds are holding shares in ALBHF

---

Alibaba Health Information Technology Stock Smart Score

Unlock Smart Score

Analyst Consensus

Moderate Buy

Average Price Target:
$0.60 (36.36% Upside)

Technicals

Fundamentals

Return on Equity

7.65%

Trailing 12-Months

Asset Growth

-1.58%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alibaba Health Information Technology

Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to provide medical and healthcare services. Its activities include self-operated healthcare product sales; e-commerce platform services; tracking services; and innovative healthcare related services and others. The company was founded on March 11, 1998 and is headquartered in Hong Kong.

---

ALBHF Stock 12 Month Forecast

Average Price Target

$0.60

▲(36.36% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.77,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.44</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"Apr<br/>2024","9":"Sep<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.53,0.55,0.5700000000000001,0.59,0.61,0.63,0.65,0.67,0.69,0.71,0.73,0.75,{"y":0.77,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.5169230769230769,0.5238461538461539,0.5307692307692308,0.5376923076923077,0.5446153846153846,0.5515384615384615,0.5584615384615385,0.5653846153846154,0.5723076923076923,0.5792307692307692,0.5861538461538461,0.5930769230769231,{"y":0.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.5046153846153846,0.49923076923076926,0.4938461538461538,0.48846153846153845,0.48307692307692307,0.4776923076923077,0.4723076923076923,0.46692307692307694,0.46153846153846156,0.45615384615384613,0.45076923076923076,0.4453846153846154,{"y":0.44,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.57,"date":1685577600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.58,"date":1693526400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1696118400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1698796800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.56,"date":1701388800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.54,"date":1704067200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.37,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.42,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Similar Stocks

Tibet Water Resources

―

CHJTF

CSPC Pharmaceutical Group

―

SBMFF

Sino Biopharmaceutical

―

CHSYF

China Medical System Holdings

―

SFOSF

Shanghai Fosun Pharmaceutical (Group) Co

―

Compare ALBHF Stocks >

Best Analysts Covering ALBHF

1 Year

Ellie JiangMacquarie

1 Year Success Rate

3/3 ratings generated profit

1 Year Average Return

+21.40%

reiterated a sell rating 25 days ago

Copying Ellie Jiang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.40% per trade.

Best Analyst Covering >

Popular Stocks

---

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing